X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB STERLING BIOTECH UNICHEM LAB/
STERLING BIOTECH
 
P/E (TTM) x 22.1 -1.8 - View Chart
P/BV x 2.3 0.1 3,282.9% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 UNICHEM LAB   STERLING BIOTECH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
STERLING BIOTECH
Dec-13
UNICHEM LAB/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs33411 3,181.0%   
Low Rs1743 5,117.6%   
Sales per share (Unadj.) Rs146.926.8 548.0%  
Earnings per share (Unadj.) Rs11.9-15.0 -79.5%  
Cash flow per share (Unadj.) Rs16.2-5.5 -296.3%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.154.9 191.5%  
Shares outstanding (eoy) m90.84267.87 33.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.70.3 666.9%   
Avg P/E ratio x21.4-0.5 -4,596.0%  
P/CF ratio (eoy) x15.7-1.3 -1,233.4%  
Price / Book Value ratio x2.40.1 1,908.2%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0731,862 1,239.4%   
No. of employees `0005.71.4 419.0%   
Total wages/salary Rs m2,558547 467.8%   
Avg. sales/employee Rs Th2,352.55,303.3 44.4%   
Avg. wages/employee Rs Th450.9403.8 111.7%   
Avg. net profit/employee Rs Th190.4-2,959.0 -6.4%   
INCOME DATA
Net Sales Rs m13,3467,181 185.9%  
Other income Rs m19243 450.5%   
Total revenues Rs m13,5387,223 187.4%   
Gross profit Rs m1,639947 173.1%  
Depreciation Rs m3902,543 15.3%   
Interest Rs m294,377 0.7%   
Profit before tax Rs m1,412-5,931 -23.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293-1,924 -15.2%   
Profit after tax Rs m1,080-4,007 -27.0%  
Gross profit margin %12.313.2 93.1%  
Effective tax rate %20.732.4 63.9%   
Net profit margin %8.1-55.8 -14.5%  
BALANCE SHEET DATA
Current assets Rs m5,97914,335 41.7%   
Current liabilities Rs m2,43249,809 4.9%   
Net working cap to sales %26.6-494.0 -5.4%  
Current ratio x2.50.3 854.3%  
Inventory Days Days63403 15.6%  
Debtors Days Days60171 35.4%  
Net fixed assets Rs m6,40355,432 11.6%   
Share capital Rs m182268 67.8%   
"Free" reserves Rs m9,29313,935 66.7%   
Net worth Rs m9,54814,701 64.9%   
Long term debt Rs m2309,478 2.4%   
Total assets Rs m12,84373,988 17.4%  
Interest coverage x50.0-0.4 -14,094.9%   
Debt to equity ratio x00.6 3.7%  
Sales to assets ratio x1.00.1 1,070.7%   
Return on assets %8.60.5 1,724.3%  
Return on equity %11.3-27.3 -41.5%  
Return on capital %14.3-6.4 -223.1%  
Exports to sales %29.225.9 112.8%   
Imports to sales %6.30.2 3,734.2%   
Exports (fob) Rs m3,9001,860 209.7%   
Imports (cif) Rs m84712 6,940.2%   
Fx inflow Rs m4,3561,860 234.2%   
Fx outflow Rs m1,16225 4,669.7%   
Net fx Rs m3,1941,835 174.1%   
CASH FLOW
From Operations Rs m1,1191,719 65.1%  
From Investments Rs m-853-3,148 27.1%  
From Financial Activity Rs m-3341,426 -23.4%  
Net Cashflow Rs m-68-3 2,008.8%  

Share Holding

Indian Promoters % 50.1 33.9 147.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 9.9 30.3%  
ADR/GDR % 0.0 16.9 -  
Free float % 31.7 39.3 80.7%  
Shareholders   20,176 21,482 93.9%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   CIPLA  SANOFI INDIA  ALKEM LABORATORIES  SHASUN PHARMA  PFIZER  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 21, 2017 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS